COA Available
Performance In Stock Research Use Only
SLU-PP-322
5mg · Lyophilized Powder · Purity ≥99%
SLU-PP-322 is a synthetic small-molecule pan-agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ, used as a pharmacological research tool to probe nuclear receptor regulation of mitochondrial biogenesis and oxidative metabolism. Supplied as a 5mg research-grade preparation.
$139.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
SLU-PP-322 is a small-molecule compound — not a peptide — that acts as a pan-agonist of the ERRα, ERRβ, and ERRγ nuclear transcription factors, which govern gene programs associated with mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation in skeletal muscle and metabolic tissues. It has been used in preclinical research as a pharmacological tool to activate ERRα-dependent transcriptional programs and study the downstream consequences on cellular energy metabolism. BME Health supplies SLU-PP-322 as a high-purity research compound for qualified laboratory use, accompanied by a Certificate of Analysis. Supplied exclusively for laboratory and research use.
In animal model studies, SLU-PP-322 has been investigated as a research tool in ERR biology, with findings in obese mouse models reporting associations between compound administration and increased energy expenditure, altered adiposity, and changes in glucose tolerance markers — all within preclinical settings. The compound is classified as an "exercise mimetic" in the research literature based on its activation of an ERRα-dependent gene expression program that overlaps with aerobic exercise-induced transcriptional responses in skeletal muscle preparations. No human pharmacokinetic or clinical safety data have been generated for SLU-PP-322. All outcomes referenced do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | SLU-PP-322 |
| Format | Lyophilized Powder |
| Size | 5mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-SLUPP3-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $139.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-SLUPP3-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store SLU-PP-322 at −20°C in a sealed, dry container protected from light. The compound should be allowed to reach room temperature under inert atmosphere before opening to prevent moisture condensation on the material. Avoid repeated freeze-thaw cycles; prepare working solutions in appropriate research-grade solvents only as required for each experimental session.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 5mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
